Skip to main content
OpenTrials

Clinical trial condition

Neoplastic Processes

Explore clinical trials studying Neoplastic Processes. Study availability and eligibility vary by location and protocol.

3,266 public trials 688 recruiting studies
Refine in advanced search Browse all conditions

Neoplastic Processes trial results

Active, Not Recruiting

Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6)

NCT04964934

Conditions
Breast Diseases, Breast Neoplasms, ER-Positive HER2-Negative Breast Cancer, +8 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Hot Springs, Arkansas, United States
  • Research Site Little Rock, Arkansas, United States
  • Research Site Long Beach, California, United States
View all 264 locations
View Trial Details
Active, Not Recruiting

Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)

NCT04886804

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Precision NextGen Oncology Beverly Hills, California, United States
  • City of Hope-Duarte-56419 Duarte, California, United States
  • City of Hope - Seacliff Huntington Beach, California, United States
View all 85 locations
View Trial Details
Active, Not Recruiting

Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer

NCT05502315

Conditions
Castration-resistant Prostate Cancer, Metastatic Cancer, Neoplasm Metastasis, +4 more
Locations
  • University of California San Diego La Jolla, California, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • University of Texas Southwestern Medical Center Dallas, Texas, United States
  • University of Wisconsin Madison, Wisconsin, United States
View Trial Details
Active, Not Recruiting

First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors

NCT05489237

Conditions
Digestive System Disease, Digestive System Diseases, Digestive System Neoplasms, +14 more
Locations
  • GSK Investigational Site Miami, Florida, United States
  • GSK Investigational Site Chicago, Illinois, United States
  • GSK Investigational Site Boston, Massachusetts, United States
  • GSK Investigational Site St Louis, Missouri, United States
View all 31 locations
View Trial Details
Active, Not Recruiting

A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)

NCT05288166

Conditions
Abiraterone Acetate, Androgens, Antineoplastic Agents, +27 more
Locations
  • Arizona Oncology Associates, P.C. - HOPE Prescott, Arizona, United States
  • Arizona Oncology Associates, P.C. - HOPE Prescott Valley, Arizona, United States
  • The University of Arizona Cancer Center - North Campus Tucson, Arizona, United States
  • Genesis Cancer and Blood Institute Hot Springs, Arkansas, United States
View all 266 locations
View Trial Details

Related conditions